Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Multiple Myeloma Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

new_biaoQian Multiple Myeloma Therapeutics

According to our (Global Info Research) latest study, the global Multiple Myeloma Therapeutics market size was valued at USD 28060 million in 2023 and is forecast to a readjusted size of USD 55320 million by 2030 with a CAGR of 10.2% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Multiple Myeloma Therapeutics Supply, Demand and Key Producers, 2023-2029

date 11 Feb 2023

date Medical Care

new_biaoQian Multiple Myeloma Therapeutics

Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

USD4480.00

Add To Cart

Add To Cart

Global Multiple Myeloma Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Medical Care

new_biaoQian Multiple Myeloma Therapeutics

Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Medical Care

new_biaoQian Multiple Myeloma Therapeutics

According to our (Global Info Research) latest study, the global Multiple Myeloma Therapeutics market size was valued at USD 28060 million in 2023 and is forecast to a readjusted size of USD 55320 million by 2030 with a CAGR of 10.2% during review period.

USD3480.00

addToCart

Add To Cart

industry 11 Feb 2023

industry Medical Care

new_biaoQian Multiple Myeloma Therapeutics

Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

USD4480.00

addToCart

Add To Cart

industry 07 Jan 2023

industry Medical Care

new_biaoQian Multiple Myeloma Therapeutics

Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

USD3480.00

addToCart

Add To Cart